2020
Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer
Miszczuk MA, Chapiro J, Geschwind JH, Thakur V, Nezami N, Laage-Gaupp F, Kulon M, van Breugel JMM, Fereydooni A, Lin M, Savic LJ, Tegel B, Wahlin T, Funai E, Schlachter T. Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer. Translational Oncology 2020, 13: 100742. PMID: 32092672, PMCID: PMC7036424, DOI: 10.1016/j.tranon.2020.01.003.Peer-Reviewed Original Research
2019
03:45 PM Abstract No. 117 Quantitative baseline imaging biomarkers for Yttrium-90 distribution on bremsstrahlung SPECT and tumor response prediction after radioembolization
Schobert I, Chapiro J, Nezami N, Hamm C, Gebauer B, Lin M, Pollak J, Saperstein L, Schlachter T, Savic L. 03:45 PM Abstract No. 117 Quantitative baseline imaging biomarkers for Yttrium-90 distribution on bremsstrahlung SPECT and tumor response prediction after radioembolization. Journal Of Vascular And Interventional Radiology 2019, 30: s55. DOI: 10.1016/j.jvir.2018.12.164.Peer-Reviewed Original ResearchTumor response predictionImaging biomarkers